Analgesics
Antiandrogens
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lactoferrin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Quercetin
Remdesivir
Vitamins

Other
Feedback
Home
Top
Abstract
All aspirin studies
Meta analysis
 
Feedback
Home
c19early.org COVID-19 treatment researchAspirinAspirin (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  

Association Study of Aspirin and Atorvastatin with Covid-19 Hospitalization: A Retrospective Longitudinal Study in Tehran

Naghibzadeh et al., Biomedical Journal of Scientific & Technical Research, doi:10.26717/BJSTR.2023.48.007623
Jan 2023  
  Twitter
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Retrospective 7,696 patients in Iran, showing aspirin use associated with a lower COVID-19 hospitalization rate for non-hypertensive patients. For hypertensive patients, there was no statistically significant association. Authors do not provide specific results for the risk of aspirin use for hypertensive patients, or for all patients overall.
Naghibzadeh et al., 24 Jan 2023, retrospective, Iran, peer-reviewed, 5 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperAspirinAll
"Association Study of Aspirin and Atorvastatin with Covid-19 Hospitalization: A Retrospective Longitudinal Study in Tehran"
Seyed Kianoosh, Hossein Lanjanian, Bita Shalbafan, Fatemeh Abdi, Maryam S Daneshpour, J Biomed, Tech Sci, Res
Biomedical Journal of Scientific & Technical Research, doi:10.26717/bjstr.2023.48.007623
COVID-19 threat is unlikely to fade soon since Global vaccination, as the best solution, is not being quickly realized. Thus, pre-exposure prophylaxis would be an available alternative strategy. This longitudinal retrospective study was done on 7696 patients referred to an Iranian hospital in the south of Tehran. The PCR result for COVID-19 and history of medications were gathered from the hospital HIS system. We investigated the possible chemoprophylaxis of the routinely recommend drugs for atherosclerosis risk control. Whit the aim of extracting the association of the pre-exposure drug history and COVID-19 history, the logistic regression model was used by adjusting for age, sex, and drug history six months before and after the pandemic. A total of 7696 individuals (12-97 yrs), 3272 men (63±14 yrs), and 4424 women (62±13.4 yrs) were studied. Among them, 581(7%) with the COVID-19 infection; 575(7%) with a hospitalization history in 6 months before the pandemic; 5809(75%) with hypertension; 2428(32%) with Ischemic Heart Disease; 2323(30%) with diabetes mellitus; 2068(26%) on metformin; 4132(54%) on Atorvastatin; 4852(62%) on Aspirin; 3907(50%) on ARBs; 638 (8%) on ACEIs; multivariable regression analysis demonstrated the strong association between pre-exposure ASA or Atorvastatin consumption and hospitalization rate due to COVID-19 as an infection severity index. Moreover, COVID-19 hospitalization rates were decreased in female hypertensive cases with ARB in their drug histories. In hypertensive subjects, comorbidity of diabetes mellitus and HTN increase the COVID-19 hospitalization rate in men by 2 .930. Someone at risk of COVID-19 infection should control their blood pressure and hyperglycemia precisely, and not only strict BP and BS control but also, Aspirin and Atorvastatin as chemoprophylaxis is highly recommended. Even the overprotection and increasing self-care during an illness may also affect the exposure to the infection.
Declarations of interest None. Ethics Approval and Consent to Participate All procedures were under the ethics committee's ethical standards on human subject research at Shahid Beheshti University of Medical Sciences (IR.SBMU.RETECH.REC.1399.576; 12. Oct.2020). The Social Security Patient Support Committee has given us access to information and they have supervised the data collection process. Of course, this information did not contain the identities of the individuals, and each person was identified by a unique code. Since, we did not do any interventions in the treatment process of individuals and only the database and registered documents were used, there is no need for consent. We confirm that all procedures are performed in accordance with the relevant instructions. Submission Declaration and Verification We declare that this manuscript is original, has not been published before, and is not currently being considered for publication elsewhere.
References
Ahmed, Gasparyan, Zimba, Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic, Rheumatol. Int
Aleksova, Ferro, Gagno, Cappelletto, Santon, COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) -Is there any scientific evidence for controversy?, J Intern Med
Aly, Ibrahim, Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?, Med. Hypotheses
Banik, Mezera, Köhler, Schmidtmann, Antiplatelet therapy in patients with Covid-19: A retrospective observational study, Thromb Updat
Chung, Karnik, Saef, Bergmann, Barnard, SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy, EBioMedicine
Clark, Mcdonagh, Mcmanus, Martin, COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society, J Hum Hypertens
Dardano, Prato, Metformin: an inexpensive and effective treatment in people with diabetes and COVID-19?, Lancet Heal Longev
De Lang, Osterhaus, Haagmans, Interferon-γ and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells, Virology
Grasselli, Zangrillo, Zanella, Antonelli, Cabrini, Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy, JAMA -J Am Med Assoc
Haitao, Vermunt, V, Abeykoon, Gunaratne, Jayachandran, COVID-19 and Sex Differences: Mechanisms and Biomarkers, Mayo Clin Proc
Kamyshnyi, Krynytska, Matskevych, Marushchak, Lushchak, Arterial hypertension as a risk comorbidity associated with covid-19 pathology, Int J Hypertens
Kow, Hasan, Meta-analysis of Effect of Statins in Patients with COVID-19, Am J Cardiol
Lanjanian, Moazzam-Jazi, Hedayati, Akbarzadeh, Guity, SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: insights from the Tehran Cardio-Metabolic Genetic Study, Sci Rep
Lanza, Perez, Costa, Thiago, Cordeiro et al., Covid-19: The renin-angiotensin system imbalance hypothesis, Clin Sci
Lee, Choi, Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective, Arch Pharm Res
Lee, Sewa, Phua, Potential role of statins in COVID-19, Int J Infect Dis
Li, Wang, Zhou, Liu, Ren, Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats, J Geriatr Cardiol
Lopachev, Kazanskaya, Khutorova, Fedorova, An overview of the pathogenic mechanisms involved in severe cases of COVID-19 infection, and the proposal of salicyl-carnosine as a potential drug for its treatment, Eur J Pharmacol
Luo, Qiu, Liu, Liu, Li, Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis, Am J Trop Med Hyg
Peymani, Dehesh, Kots, Sadeghdoust, Kotfis, Statins in Patients with COVID-19: A Retrospective Cohort Study in Iranian COVID-19 Patients, Transl Med Commun
Rabi, Khan, Vallee, Sw Tobe, Pilote, Reporting on sexbased analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy, Can J Cardiol
Richardson, Hirsch, Narasimhan, Crawfor, Mcginn, Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area, JAMA -J Am Med Assoc
Rossi, Talarico, Coppi, Boriani, Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action, Intern Emerg Med
Sharma, Ray, Sadasivam, Metformin in COVID-19: A possible role beyond diabetes, Diabetes Res Clin Pract
Speth, Angiotensin II administration to COVID-19 patients is not advisable, Crit Care
Stawicki, Jeanmonod, Miller, Gaieski, Yaffee, The 2019-2020 novel coronavirus (severe acute respiratory syndrome coronavirus 2) pandemic: A joint american college of academic international medicine-world academic council of emergency medicine multidisciplinary COVID-19 working group consensus paper, J Glob Infect Dis
Takahashi, Ellingson, Wong, Israelow, Lucas, Sex differences in immune responses that underlie COVID-19 disease outcomes, Nature
Urbach, Awiszus, Leiß, Vincent De, Specht et al., Associations of medications with lower odds of typical COVID-19 symptoms: Cross-sectional symptom surveillance study, JMIR Public Heal Surveill
Vitiello, Porta, Ferrara, Correlation between the use of statins and COVID-19: what do we know?, BMJ Evidence-Based Med Mon
Wang, Tse, Li, ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19, J Am Coll Cardiol
Wenzel, Turner, Krebs, David G Harrison, Ehmke, Immune mechanisms in arterial hypertension, J Am Soc Nephrol
Yang, Yu, Xu, Xia, Liu, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med
Yuan, Chen, Li, Chen, Wang, Mortality and prehospitalization use of low-dose aspirin in COVID-19 patients with coronary artery disease, J Cell Mol Med
Zhang, Zhu, Cai, Xie, Liu, Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality among Patients with Hypertension Hospitalized with COVID-19, Circ Res
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit